Cardiovascular Safety of Atomoxetine in Children With ADHD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This prospective observational cohort study aims to evaluate the cardiovascular safety of atomoxetine therapy in children with attention-deficit/hyperactivity disorder during the first six months of treatment.
Epistemonikos ID: 5b9a2a78f2463b610906f4d674f7120717ced78e
First added on: Oct 06, 2026